S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Stock market today: Tumbling tech stocks drag Wall Street to the finish line of another losing week
American Express profits jump 34%, helped by jump in new customers, higher spending
How major US stock indexes fared Friday, 4/19/2024
American Express, Fifth Third rise; Netflix, PPG Industries fall, Friday, 4/19/2024
Intuitive Surgical Stock Can Trend Much Higher This Year 
3 Magnificent Seven Stocks Outperforming the Rest
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
NYSE:ARNC

Arconic (ARNC) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$29.98
$30.02
50-Day Range
$29.56
$29.99
52-Week Range
$16.33
$30.02
Volume
4.38 million shs
Average Volume
1.57 million shs
Market Capitalization
$3.01 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ARNC stock logo

About Arconic Stock (NYSE:ARNC)

Arconic Corporation manufactures and sells fabricated aluminum sheets, plates, extrusions, and architectural products and systems in the United States and internationally. It operates through three segments: Rolled Products, Building and Construction Systems, and Extrusions. The Rolled Products segment provides a range of aluminum sheet and plate products for aerospace, ground transportation, packaging, building and construction, and industrial products; and roofing, architectural composite panels, ventilated facades and ceiling panels, spacers, culvert pipes, and gutters for building and construction markets. The Building and Construction Systems segment provides various products and building envelope solutions, such as entrances, curtain walls, windows, composite panels, and coil coated sheets for fabricators and glazing subcontractors under the Kawneer, Reynobond, and Reynolux brands. The Extrusions segment offers extruded products, such as automotive shapes, aerospace shapes, seamless tubes, hollows, mortar fins, and high strength rods and bars for ground transportation, aerospace, and industrial markets. The company offers its products directly to customers, as well as through distributors. The company was formerly known as Arconic Rolled Products Corporation and changed its name to Arconic Corporation in April 2020. Arconic Corporation was founded in 1888 and is headquartered in Pittsburgh, Pennsylvania.

ARNC Stock News Headlines

Car drives into pond near Arconic
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
20 Most Trustworthy Cities in the US
Arconic Bald Eagles start another family
Arconic confirms bald eagle has laid an egg
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
Arnoya classic USD (ARNC-USD)
Arconic names Marcelo Morgueta new CFO
Arconic Names Marcelo Morgueta Chief Financial Officer
Arconic Appoints Chris Ayers As CEO
Arconic Names Chris Ayers CEO and Chairman of the Board
Arconic Completes Transaction with Apollo Funds
Arconic (ARNC) Tops Q2 Earnings Estimates
Arconic Inc. Q2 Income Retreats, but beats estimates
Arconic Reports Second Quarter 2023 Results
See More Headlines
Receive ARNC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arconic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
7/31/2023
Today
4/19/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Rolling, drawing, & extruding of nonferrous metals
Sub-Industry
N/A
CIK
4281
Fax
N/A
Employees
11,550
Year Founded
N/A

Profitability

Net Income
$-182,000,000.00
Pretax Margin
-3.54%

Debt

Sales & Book Value

Annual Sales
$8.96 billion
Cash Flow
$3.81 per share
Book Value
$14.79 per share

Miscellaneous

Free Float
99,553,000
Market Cap
$3.01 billion
Optionable
Optionable
Beta
1.82
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives


ARNC Stock Analysis - Frequently Asked Questions

Should I buy or sell Arconic stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Arconic in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" ARNC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ARNC, but not buy additional shares or sell existing shares.
View ARNC analyst ratings
or view top-rated stocks.

How were Arconic's earnings last quarter?

Arconic Co. (NYSE:ARNC) issued its quarterly earnings data on Monday, July, 31st. The basic materials company reported $0.58 EPS for the quarter, beating analysts' consensus estimates of $0.50 by $0.08. The basic materials company had revenue of $1.99 billion for the quarter, compared to analysts' expectations of $2.05 billion. Arconic had a positive trailing twelve-month return on equity of 8.18% and a negative net margin of 3.12%. The firm's quarterly revenue was down 21.9% on a year-over-year basis. During the same quarter last year, the business earned $1.05 earnings per share.

What ETFs hold Arconic's stock?

ETFs with the largest weight of Arconic (NYSE:ARNC) stock in their portfolio include Direxion Daily Metals & Mining Bull 2X Shares (MNM).SPDR S&P 600 Small Cap ETF (SLY).

How will Arconic's stock buyback program work?

Arconic announced that its Board of Directors has authorized a stock buyback program on Wednesday, November 16th 2022, which authorizes the company to buyback $200,000,000.00 in shares, according to EventVestor. This buyback authorization authorizes the company to buy up to 9.9% of its stock through open market purchases. Stock buyback programs are generally a sign that the company's board of directors believes its shares are undervalued.

What is Mr. John C. Plant's approval rating as Arconic's CEO?

73 employees have rated Arconic Chief Executive Officer Mr. John C. Plant on Glassdoor.com. Mr. John C. Plant has an approval rating of 34% among the company's employees. This puts Mr. John C. Plant in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Arconic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Arconic investors own include Alcoa (AA), Bank of America (BAC), Cisco Systems (CSCO), Boeing (BA), General Electric (GE), Advanced Micro Devices (AMD), AT&T (T), Micron Technology (MU), NVIDIA (NVDA) and QUALCOMM (QCOM).

This page (NYSE:ARNC) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners